DMAb extends NVFx reduction in postmenopausal osteoporosis out to 10 y | ASBMR

Long-term reduction in bone remodeling is associated with a favorable benefit/risk profile for bone.
Long-term reduction in bone remodeling is associated with a favorable benefit/risk profile for bone.